As I step into my role as the incoming President of the AST, I am grateful for the past leadership, led by the guidance of Past President, Dr. Deepali Kumar. I would also like to congratulate the newly elected President-elect, Jon Kobashigawa, Secretary, Nicole Turgeon, and our new Councilors-at-Large: John Friedewald, Matthew Cooper, and Shelley Hall. Furthermore, I would like to thank the outgoing Board members: John Gill, Sean Pinney, Linda Ohler, and Beau Kelly for their invaluable contributions. As we embark on a new chapter, I am thrilled to reflect on our recent accomplishments and share my vision for the year.
Over the last year, the AST hosted over 25 webinars and Journal Clubs, covering various transplant topics. These virtual events have fostered a sense of collaboration, allowing transplant professionals worldwide to come together and exchange invaluable insights.
In addition to our virtual initiatives, we successfully transitioned back to hosting in-person meetings. We were thrilled to host the Cutting Edge of Transplantation (CEoT), American Transplant Congress (ATC), Fellows Symposium, and Future of Transplantation meetings in person again.
In the past year, we proudly awarded nearly $1.1 million in research grants. Furthermore, through our public policy efforts, we continued to advocate for the Living Donor Protection Act and addressed other key transplant-related issues.
Nearly ten years ago, I made this statement on an application for a Board position: "I see my involvement in the AST as a lifetime effort, with further involvement at even higher levels than a Councilor position." Becoming a Councilor, Treasurer, and now the AST President is truly a culmination of these goals and an absolute privilege. More than ever, the AST is the most important Society and home for all organ transplantation disciplines. The direction the Society is heading is simply nothing short of amazing, flourishing during difficult times as we come through the COVID-19 pandemic. I am excited to lead the Society moving forward, promoting patient/donor advocacy, education, and research missions, and continuing the charge to be more inclusive, diverse, and equitable. I have always believed that the AST is the "mother ship" and connector for all transplantation disciplines. No other society is all-encompassing and comprehensive like the AST, which emphasizes all transplant fields via research, education, advocacy, and donation missions. This is what makes the AST unique and, as such, I will emphasize efforts that cross multiple disciplines to bring people together for uniformity and consensus.
During Dr. Kumar's productive year as the AST President, the Board hired an outside firm to help synthesize and formulate the Society's strategic plan, with all board members providing input. The Strategic Plan is now posted on the website, but it is our job to carry out the strategic plan at the Board and COP level to focus our efforts on solid organ transplantation in the most productive, effective places. Thus, it made sense to me to outline my goals for my year as the AST President under the strategic goal headings as follows:
Continuous Innovation
Engaging Members
Serving our Patients and the Broader Society
Developing the Workforce
A Future-enabled AST
As I step into my role as the incoming President of the AST, I am filled with optimism for the future. I look forward to working and collaborating with our membership for another successful year at the AST.